A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 507
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : TGF-beta2
Long Form : transforming growth factor-beta2
No. Year Title Co-occurring Abbreviation
1988 Mesoderm induction in amphibians: the role of TGF-beta 2-like factors. ---
1988 Structural and sequence analysis of TGF-beta 2 cDNA clones predicts two different precursor proteins produced by alternative mRNA splicing. ---
1989 Expression and characterization of recombinant TGF-beta 2 proteins produced in mammalian cells. CHO, TGF-beta1
1989 Expression of transforming growth factor beta 2 RNA during murine embryogenesis. p.c, PP
1989 Murine transforming growth factor-beta 2 cDNA sequence and expression in adult tissues and embryos. ---
1989 The growth inhibitor of African green monkey (BSC-1) cells is transforming growth factors beta 1 and beta 2. ---
1990 A novel polyclonal antibody (CL-B1/29) for immunolocalization of transforming growth factor-beta 2 (TGF-beta 2) in adult mouse. ---
1990 A transforming growth factor beta 2 (TGF-beta 2)-like immunosuppressive factor in amniotic fluid and localization of TGF-beta 2 mRNA in the pregnant uterus. MAF, TGF-beta
1990 Antibodies to transforming growth factor-beta 2 peptides: specific detection of TGF-beta 2 in immunoassays. ---
10  1990 Characterization of polyclonal anti-peptide antibodies specific for transforming growth factor beta 2. ---
11  1990 Co-localization of transforming growth factor beta 2 with alpha 1(I) procollagen mRNA in tissue sections of patients with systemic sclerosis. DM, SLE, SSc
12  1990 Complementary deoxyribonucleic acid cloning of an mRNA encoding transforming growth factor-beta 2 from chicken embryo chondrocytes. ---
13  1990 Cytokine regulation of intercellular adhesion molecule-1 (ICAM-1) expression on human glioblastoma cells. ICAM-1, IFN-gamma, IL-1 beta, LFA-1, TNF-alpha
14  1990 Expression of transforming growth factor beta 2 during the differentiation of murine embryonal carcinoma and embryonic stem cells. EC, ES, RA
15  1990 High-level expression of TGF-beta 2 and the TGF-beta 2(414) precursor in Chinese hamster ovary cells. CHO
16  1990 Increased expression of genes for basic fibroblast growth factor and transforming growth factor type beta 2 in human benign prostatic hyperplasia. BPH, EGF, FGF
17  1990 Induction and autocrine receptor binding of transforming growth factor-beta 2 during terminal differentiation of primary mouse keratinocytes. ---
18  1990 Role of interferon-gamma in counteracting the suppressive effects of transforming growth factor-beta 2 and glucocorticoids on the production of tumor necrosis factor-alpha. IFN-gamma, LPS, TNF-alpha
19  1990 Sequence analysis of the promoter region of the glioblastoma derived T cell suppressor factor/transforming growth factor (TGF)-beta 2 gene reveals striking differences to the TGF-beta 1 and -beta 3 genes. G-TsF, TGF
20  1990 Transforming growth factor beta 2 differentially modulates interleukin-1 beta- and tumour-necrosis-factor-alpha-stimulated phospholipase A2 and prostaglandin E2 synthesis in rat renal mesangial cells. IL-1 beta, PGE2, TNF-alpha
21  1991 Antiproliferative and differentiative effects of recombinant interleukin-4 on a granulocyte colony-stimulating factor-dependent myeloblastic leukemic cell line. alpha-NB, G-CSF, IL-4, TNF-alpha
22  1991 Characterization of latent transforming growth factor-beta 2 from monkey kidney cells. ---
23  1991 Comparative analysis of human and chicken transforming growth factor-beta 2 and -beta 3 promoters. ---
24  1991 Cytokines in proliferative vitreoretinopathy. FPA, IFN-gamma, IL-1, IL-6, PVR, RD, TNF-alpha, TNF-beta
25  1991 Differential localization of TGF-beta 2 in mouse preimplantation and early postimplantation development. ---
26  1991 Growth-factor-related proteins that are inducers in early amphibian development may mediate similar steps in amniote (bird) embryogenesis. bFGFs, PDGF
27  1991 Molecular cloning and primary structure of the chicken transforming growth factor-beta 2 gene. ---
28  1991 Molecular cloning and structure of the human transforming growth factor-beta 2 gene promoter. CAT
29  1991 Rat thecal/interstitial cells express transforming growth factor-beta type 1 and 2, but only type 2 is regulated by gonadotropin in vitro. RT-PCR, TIC
30  1991 Transforming growth factor beta 2 inhibits interleukin 1 beta- and tumour necrosis factor alpha-induction of nitric oxide synthase in rat renal mesangial cells. IL-1 beta, NO, TNF-alpha
31  1991 Transforming growth factor-beta regulation of IL-6 production by unstimulated and IL-1-stimulated human fibroblasts. TGF-beta1
32  1992 An unusual feature revealed by the crystal structure at 2.2 A resolution of human transforming growth factor-beta 2. ---
33  1992 Cell-type-specific localization of transforming growth factor-beta 2 and transforming growth factor-beta 1 in the hamster ovary: differential regulation by follicle-stimulating hormone and luteinizing hormone. TGF-beta1
34  1992 Characterization of N-terminal amino acid sequence of monoclonal nonspecific suppressor factor. MNSF
35  1992 Crystallization and preliminary X-ray analysis of recombinant human transforming growth factor beta 2. ---
36  1992 Modulation of human IgE synthesis by transforming growth factor-beta. IL-4, PMBC
37  1992 Porcine granulosa cells do not express transforming growth factor-beta 2 (TGF-beta 2) messenger ribonucleic acid: molecular basis for their inability to produce TGF-beta activity comparable to that of rat granulosa cells. bp, GC, mRNA, RT-PCR, TGF-beta
38  1992 Synergistic effects of dexamethasone on platelet-derived growth factor mitogenesis in vitro. IGF-I, PDGF
39  1992 Transforming growth factor-beta 2 for the treatment of full-thickness macular holes. A prospective randomized study. ---
40  1993 Estrogenic actions of RU486 in hormone-responsive MCF-7 human breast cancer cells. ER
41  1993 Identification and molecular characterization of a high-affinity cardiomyocyte transforming growth factor-beta 2 receptor. ---
42  1993 Production of multiple growth factors by a human non-small cell lung carcinoma cell line. bFGF, EGF, HUV, PDGF, TGF alpha, TGF-beta1, TNF-alpha
43  1993 Refined crystal structure of human transforming growth factor beta 2 at 1.95 A resolution. ---
44  1993 The effect of interleukin 2 and transforming growth factor-beta 2 (TGF-beta 2) on the proliferation and natural killer activity of decidual CD16- CD56bright natural killer cells. IL-2R alpha, IL-2R beta, NK
45  1993 The effect of pars plana vitrectomy and transforming growth factor-beta 2 without epiretinal membrane peeling on full-thickness macular holes. ---
46  1994 Aqueous humor in glaucomatous eyes contains an increased level of TGF-beta 2. POAG
47  1994 Effects of intraocular bubble duration in the treatment of macular holes by vitrectomy and transforming growth factor-beta 2. air
48  1994 Effects of TGF-beta 2 on mineral resorption in cultured embryonic mouse long bones; 45Ca release and osteoclast differentiation and migration. TRAP
49  1994 Effects of TGF-beta and TGF-beta neutralizing antibodies on fibroblast-induced collagen gel contraction: implications for proliferative vitreoretinopathy. PVR
50  1994 Expression of transforming growth factor-beta 2 in malignant melanoma correlates with the depth of tumor invasion. Implications for tumor progression. ---
51  1994 Increased production of transforming growth factor-beta 2 from cultured human retinal pigment epithelial cells by photocoagulation. RPE
52  1994 Inhibitory effect of TGF-beta 2 in human aqueous humor on bovine lens epithelial cell proliferation. BLECs
53  1994 Interleukin 10 up-regulates elastin gene expression in vivo and in vitro at the transcriptional level. CAT, IL-10
54  1994 Interleukin-8, interleukin-6, and soluble tumour necrosis factor receptor type I release from a human pulmonary epithelial cell line (A549) exposed to respiratory syncytial virus. GM, IFN-gamma, IL-6, IL-8, RSV, sTNFR
55  1994 Low mature TGF-beta 2 levels in aqueous humor during uveitis. ---
56  1994 Production of interleukin-6 and interleukin-8 by human mammary gland epithelial cells. IL-1 beta, TNF-alpha
57  1994 Regulation of protein kinase C activity by phorbol ester, thrombin, parathyroid hormone and transforming growth factor-beta 2 in different types of osteoblastic cells. PKC, ROB
58  1994 Sequential expression of acetylcholine receptor isoforms in mesodermalized Xenopus animal caps. ---
59  1994 Therapeutic effect of transforming growth factor-beta 2 on actively induced EAN but not adoptive transfer EAN. AT, AT-EAN, EAN, i.p, MHC, PNS
60  1994 Transforming growth factor beta 2 stimulates acute and chronic activation of the mitogen-activated protein kinase cascade in rat renal mesangial cells. MAP kinase, MEK
61  1994 Transforming growth factor beta isoform 2-specific high affinity binding to native alpha 2-macroglobulin. Chimeras identify a sequence that determines affinity for native but not activated alpha 2-macroglobulin. alpha 2M
62  1994 Transforming growth factor-beta 2 levels increase following retinal laser photocoagulation. ---
63  1994 Transforming growth factor-beta-2 (TGF-beta 2) is associated with mature rat neuromuscular junctions. ---
64  1995 Accumulation of chromotrope 2R positive cells in equine endometrium during early pregnancy and expression of transforming growth factor-beta 2 (TGF-beta 2). ---
65  1995 Altered gene expression in murine branchial arches following in utero exposure to retinoic acid. CREB, GD, NAChR, RA, RARgamma
66  1995 Characterization of murine pregnancy decidua transforming growth factor beta. I. Transforming growth factor beta 2-like molecules of unusual molecular size released in bioactive form. FBS
67  1995 Down-regulation of the receptor for parathyroid hormone (PTH) and PTH-related peptide by transforming growth factor-beta in primary fetal rat osteoblasts. mRNA, PTH
68  1995 Expression of MHC antigens by intestinal epithelial cells. Effect of transforming growth factor-beta 2 (TGF-beta 2). IFN-gamma
69  1995 Growth factors in human ovarian follicle fluid and growth factor receptors in granulosa-luteal cells. EGF, IGF-I, PDGF-AB, TGF alpha
70  1995 Growth factors influence contractility and alpha-smooth muscle actin expression in bovine lens epithelial cells. alpha-SMA, bFGF, LECs
71  1995 Immunolocalization of transforming growth factor-beta 1 and transforming growth factor-beta 2 in the mouse ovary during gonadotrophin-induced follicular maturation. hCG, PMSG, TGF-beta1
72  1995 Influence on collagen metabolism of vitreous from eyes with proliferative vitreoretinopathy. PVR
73  1995 Insect prothoracicotropic hormone: a new member of the vertebrate growth factor superfamily. beta-NGF, PDGF-BB, PTTH
74  1995 Overproduction of inhibitory hematopoietic cytokines by lipopolysaccharide-activated peripheral blood mononuclear cells in patients with aplastic anemia. AA, BM, CM, IFN-gamma, IL-3, LPS, MIP-1alpha, PBMNC, SCF, TNF-alpha
75  1995 Regulation of retinal glial cell proliferation by antiproliferative molecules. PKC
76  1995 Relationship between basic fibroblast growth factor and transforming growth factor-beta 2 in breast cyst fluid. bFGF
77  1995 Stress-triggered abortion: inhibition of protective suppression and promotion of tumor necrosis factor-alpha (TNF-alpha) release as a mechanism triggering resorptions in mice. TNF-alpha
78  1995 T cell apoptosis induced by interleukin-2 deprivation or transforming growth factor-beta 2: modulation by the phosphatase inhibitors okadaic acid and calyculin A. IL-2
79  1995 The expression of collagen mRNAs in normally developing neonatal rabbit long bones and after treatment of neonatal and adult rabbit tibiae with transforming growth factor-beta 2. ---
80  1995 Transforming growth factor beta 2 (TGF-beta 2) levels in plasma of patients with metastatic breast cancer treated with tamoxifen. ---
81  1996 Amelioration of rat experimental arthritides by treatment with the alkaloid sinomenine. AA, AIA, ESR, i.p, IL-1 beta
82  1996 Apoptosis in adult mouse testis induced by experimental cryptorchidism. p.c
83  1996 Apoptosis in human alveolar macrophages is induced by endotoxin and is modulated by cytokines. AM, G-CSF, GM-CSF, IFN-gamma, IL-1 beta, ISDE, LPS, M-CSF, TNF-alpha
84  1996 Closure of persistent macular holes with human recombinant transforming growth factor-beta 2. ---
85  1996 Differential regulation of TGF-beta 2 by hormones in rat uterus and mammary gland. ---
86  1996 Effect of transforming growth factor-beta on plasminogen activator production of cultured human uveal melanoma cells. PA, tPA
87  1996 Effects of dexamethasone and transforming growth factor-beta 2 on group II phospholipase A2 mRNA and activity levels in interleukin 1 beta- and forskolin-stimulated mesangial cells. IL-1 beta, sPLA2
88  1996 Effects of the cytokines on the proliferation of and collagen synthesis by human cataract lens epithelial cells. bFGF, IL-1, IL-1ra, LECs
89  1996 Extraosseous primary and recurrent giant cell tumors: transforming growth factor-beta1 and -beta2 expression may explain metaplastic bone formation. GCT, mRNA, TGF-beta1
90  1996 Increased intraocular pressure after macular hole surgery. ---
91  1996 Insulin-like growth factor binding protein 3 mediates retinoic acid- and transforming growth factor beta2-induced growth inhibition in human breast cancer cells. IGFBP, ODN, RA
92  1996 Insulin-like growth factor binding protein-3 in breast cyst fluid: relationships with insulin-like growth factors I and II and transforming growth factor-beta 1 and 2. IGFBP-3, TGF-beta1
93  1996 Intrafollicular insulin-like growth factor-II levels in normally ovulating women and in patients with polycystic ovary syndrome. EGF, EIA, FF, IGF-II, LHRH, PCOS
94  1996 Production of hematopoietic regulatory cytokines by peripheral blood mononuclear cells in patients with aplastic anemia. AA, BM, CM, GM-CSF, IFN-gamma, IL-3, MIP-1alpha, PBMNC, PHA, SCF, TNF-alpha
95  1996 Reoperation after failed macular hole surgery. ETDRS
96  1996 Soluble mediators and cytokines produced by human CD3- leucocyte clones from decidualized endometrium. dGL, GM-CSF, IL-2, pbNK, TNF-alpha
97  1996 TGF-beta 2 increases alpha-smooth muscle actin expression in bovine retinal pigment epithelial cells. FBS, RPE, SMA
98  1996 The actions of 2,3,7,8-tetrachlorodibenzo-p-dioxin on transforming growth factor-beta2 promoter activity are localized to the TATA box binding region and controlled through a tyrosine kinase-dependent pathway. TCDD
99  1996 The regulation of heme turnover and carbon monoxide biosynthesis in cultured primary rat olfactory receptor neurons. CO, HO
100  1996 Transcription of the transforming growth factor-beta2 gene is dependent on an E-box located between an essential cAMP response element/activating transcription factor motif and the TATA box of the gene. ---
101  1996 Transforming growth factor-beta 2 both stimulates and inhibits neurogenesis of rat cerebellar granule cells in culture. ---
102  1996 Transforming growth factor-beta2 increases NMDA receptor-mediated excitotoxicity in rat cerebral cortical neurons independently of glia. NMDA
103  1996 Transforming growth factor-beta2-mediated regulation of C3 gene expression in monocytes. ---
104  1996 Vitreous body affects activation and maturation of monocytes into macrophages. ---
105  1997 1,25-dihydroxyvitamin D3 regulates the expression of N-myc, c-myc, protein kinase C, and transforming growth factor-beta2 in neuroblastoma cells. NGF, PKC
106  1997 Articular chondrocytes produce factors that inhibit maturation of sternal chondrocytes in serum-free agarose cultures: a TGF-beta independent process. ---
107  1997 Cellular localisation of transforming growth factor-beta 2 and -beta 3 (TGF-beta2, TGF-beta3) in damaged and regenerating skeletal muscles. TGF-beta2, TGF-beta3
108  1997 Cytokine production in synovial tissue of mice with collagen-induced arthritis (CIA). CIA, IFN-gamma, RA, TNF-alpha
109  1997 Human osteoblast response in vitro to platelet-derived growth factor and transforming growth factor-beta delivered from controlled-release polymer rods. EVA
110  1997 Insulin-like growth factor binding protein-3 and -5 are regulated by transforming growth factor-beta and retinoic acid in the human prostate adenocarcinoma cell line PC-3. IGFBPs, IGFs, RA, TGF-beta
111  1997 Microgravity reduces the differentiation of human osteoblastic MG-63 cells. ALP
112  1997 Murine T cell determination of pregnancy outcome: I. Effects of strain, alphabeta T cell receptor, gammadelta T cell receptor, and gammadelta T cell subsets. TCR
113  1997 Neurons promote macrophage proliferation by producing transforming growth factor-beta2. CSF-1
114  1997 PGE2, but not TGF beta 2, in rabbit blastocoelic fluid regulates the cytotoxic activities of NK and LAK cells. 6KPGF 1 alpha, LAK, NK, PGE2
115  1997 Soluble receptors neutralizing TNF-alpha and IL-1 block stress-triggered murine abortion. IL-1, SP, TNF-alpha
116  1997 Surgical management of macular holes: results using gas tamponade alone, or in combination with autologous platelet concentrate, or transforming growth factor beta 2. ---
117  1997 TGF beta 2 in rabbit blastocoelic fluid regulates CD4 membrane expression: possible role in the success of gestation. ABC, BF, BF d-12, Con A, PBL
118  1997 TGF-beta 2 and PGE2 in rabbit blastocoelic fluid can modulate GM-CSF production by human lymphocytes. Con A, ELISA, GM-CSF, IFN-gamma, IL-10, IL-4, PBL, PGE2, TNF-alpha
119  1997 TGFbeta regulation of mitogen-activated protein kinases in human breast cancer cells. BCC, ERK2, MAPKs, PAI-1, SAPK/JNK
120  1997 TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes. ---
121  1997 The immunohistochemical localization of transforming growth factor-beta 2 in the fetal and neonatal rat testis. ---
122  1997 Tractional force generation by porcine Muller cells. Development and differential stimulation by growth factors. CAII, CRALBP, GFAP, IGF-I, PDGF, TGF-beta1
123  1997 Transforming growth factor-beta 2 inhibits interleukin 1 beta-induced expression of inducible nitric oxide synthase in rat renal mesangial cells. IL-1 beta, iNOS
124  1997 Transforming growth factor-beta2 selectively alters the developmental expression of the fast transient A-current in cultured rat superior cervical ganglion neurons. SCG
125  1998 Analysis of extracellular matrix synthesis during wound healing of retinal pigment epithelial cells. ECM, EGF, PDGF, RPE
126  1998 Association of genetic polymorphisms in the ACE, ApoE, and TGF beta genes with early onset ischemic heart disease. ACE, APOE, IHD
127  1998 Comparison of recombinant transforming growth factor-beta-2 and placebo as an adjunctive agent for macular hole surgery. ---
128  1998 Determination of transforming growth factor-beta 2 (TGF-beta 2) in bovine colostrum samples. ---
129  1998 Differential expression of cytokine transcripts in human epithelial ovarian carcinoma by solid tumour specimens, peritoneal exudate cells containing tumour, tumour-infiltrating lymphocyte (TIL)-derived T cell lines and established tumour cell lines. EOC, IFN-gamma, PEC, rIL-2, RT-PCR, TIL
130  1998 Effects of transforming growth factor-beta 2, interleukin 6 and fibronectin on corneal epithelial wound healing. IL-6
131  1998 Gene expression related to the differentiation of osteoblastic cells is altered by microgravity. mRNA, RT-PCR
132  1998 Improved local delivery of TGF-beta2 by binding to injectable fibrillar collagen via difunctional polyethylene glycol. FC, PEG, PEG-TGF-beta2
133  1998 Partial antagonism between steroidal and nonsteroidal antiestrogens in human breast cancer cell lines. ERs
134  1998 The lens influences aqueous humor levels of transforming growth factor-beta 2. i.o.f
135  1998 Time course of immunological markers in patients with the systemic inflammatory response syndrome: evaluation of sCD14, sVCAM-1, sELAM-1, MIP-1 alpha and TGF-beta 2. ELAM-1, ELISA, IL, MIP, SIRS, VCAM-1
136  1998 Transforming growth factor beta 2 (TGF beta 2) and dehydroepiandrosterone sulphate (DHEAs) levels in breast macrocyst fluids. Different behaviour according to cyst type. DHEAS
137  1998 Transforming growth factor beta2 in the vitreous in proliferative diabetic retinopathy. PDR
138  1999 Altered plasma levels of nerve growth factor and transforming growth factor-beta2 in type-1 diabetes mellitus. NGF
139  1999 Analysis of the secretion pattern of monocyte chemotactic protein-1 (MCP-1) and transforming growth factor-beta 2 (TGF-beta2) by human retinal pigment epithelial cells. MCP-1, RPE
140  1999 Anterior chamber-associated immune deviation-inducing cells activate T cells, and rescue them from antigen-induced apoptosis. ACAID, IL-12, OVA, PEC, Th1, TNF-alpha
141  1999 Differential expression of and responsiveness to transforming growth factor-beta (TGF-beta) isoforms in hormone-dependent and independent lines of mouse mammary tumors. HD, MPA, TGF-beta
142  1999 Distinct roles for transforming growth factor-beta2 and tumour necrosis factor-alpha in immune deviation elicited by hapten-derivatized antigen-presenting cells. APC, CH, TNF-alpha
143  1999 Dynamics of protein 27 of avian leukosis virus and transforming growth factor beta2 in lymphoid leukosis susceptible and resistant broiler chicken breeding stock. LL
144  1999 Expression of vitreous cytokines in proliferative vitreoretinopathy: a prospective study. bFGF, ILs, PVR
145  1999 Human astrocytomas co-expressing Fas and Fas ligand also produce TGFbeta2 and Bcl-2. Bcl-2, FasL, WHO
146  1999 Latent forms of transforming growth factor-beta 2 (TGF-beta 2) in breast cyst fluid. TGF-beta
147  1999 Localization of transforming growth factor-beta receptor types I, II, and III in the postnatal rat small intestine. ---
148  1999 Loss of anterior chamber-associated immune deviation (ACAID) in aged retinal degeneration (rd) mice. ACAID, ND, RCS, rd
149  1999 Temporal and spatial aspects of fragmentation in early human embryos: possible effects on developmental competence and association with the differential elimination of regulatory proteins from polarized domains. EGF-R, STAT3, VEGF
150  1999 Temporo-spatial expression of bFGF and TGFbeta2 in embryonic dopaminergic grafts in a rat model of Parkinson's disease. bFGF
151  1999 Testicular-associated immune deviation and prevention of adjuvant-induced arthritis by three tolerization methods. ACAID, AIA, AVID, TAID
152  1999 Transcriptional regulation of the transforming growth factor-beta2 promoter by cAMP-responsive element-binding protein (CREB) and activating transcription factor-1 (ATF-1) is modulated by protein kinases and the coactivators p300 and CREB-binding protein. ATF1, CRE/ATF, CREB, EC
153  1999 Transdifferentiation of NRP-152 rat prostatic basal epithelial cells toward a luminal phenotype: regulation by glucocorticoid, insulin-like growth factor-I and transforming growth factor-beta. TbetaRII
154  2000 A porcine intrauterine 4-mda component with transforming growth factor-beta activity suppresses natural killer cell responses. LAK, NK, PBL
155  2000 Activation of ionotropic glutamate receptors reduces the production of transforming growth factor-beta2 by developing neurons. AMPA, NMDA
156  2000 Chondrogenic potential of in vitro multiplied rabbit perichondrium cells cultured in alginate beads in defined medium. IGF-1
157  2000 Evidence for multiple CD95-CD95 ligand interactions in anteriorchamber-associated immune deviation induced by soluble protein antigen. ACAID, APC, DH, OVA
158  2000 Ex vivo canine lens capsular sac explants. IGF-1, LEC, PCO, Tf
159  2000 Growth regulation of bovine retinal pericytes by transforming growth factor-beta2 and plasmin. ELISA
160  2000 Long-term TGFbeta2 protein expression in heterotopic cortical grafts located in the rat striatum. IR
161  2000 Measurement of T-cell-derived antigen binding molecules and immunoglobulin G specific to Candida albicans mannan in sera of patients with recurrent vulvovaginal candidiasis. CTAB, IgG, TABM
162  2000 Morphologic and functional determinants of primordial and primary follicles in the monkey ovary. SCF, TGF alpha
163  2000 Nitric oxide augments release of chemokines from monocytic U937 cells: modulation by anti-inflammatory pathways. IL-8, MAP, NO
164  2000 Retinoic acid resistance at late stages of human papillomavirus type 16-mediated transformation of human keratinocytes arises despite intact retinoid signaling and is due to a loss of sensitivity to transforming growth factor-beta. HKc, RA
165  2000 Retinoic acid-dependent transforming growth factor-beta 2-mediated induction of MUC4 mucin expression in human pancreatic tumor cells follows retinoic acid receptor-alpha signaling pathway. RA, RAR
166  2000 The expression and structure of TGF-beta2 transcripts in rat muscles. ---
167  2000 Transforming growth factor-beta2 mediates mesenchymal-epithelial interactions of testicular somatic cells. ---
168  2000 Transforming growth factor-beta: a growth factor inducing alpha B-crystallin expression in ciliary muscle cells. CM, TM
169  2000 VSM growth is stimulated in sympathetic neuron/VSM cocultures: role of TGF-beta2 and endothelin. SCG, VSM
170  2001 Comparing transforming growth factor beta-2 and fibronectin as pleurodesing agents. ---
171  2001 Cytokine manipulation of explanted Dupuytren's affected human palmar fascia. ---
172  2001 DNA array analysis of the developing rat cerebellum: transforming growth factor-beta2 inhibits constitutively activated NF-kappaB in granule neurons. NF-kappaB, NGF
173  2001 Effect of transforming growth factor-beta 2 on phagocytosis in cultured bovine trabecular meshwork cells. ---
174  2001 Expression of chemokine by human coronary-artery and umbilical-vein endothelial cells and its regulation by inflammatory cytokines. gammaIP-10, HCAEC, HUVEC, mRNA, RANTES, TNF-alpha
175  2001 Expression profiles of endometrial leukemia inhibitory factor, transforming growth factor beta2 (TGFbeta2), and TGFbeta2 receptor in infertile bonnet monkeys. LIF, RT-PCR, TGFbeta2R
176  2001 Extracellular matrix production of lens epithelial cells. ECM, LECs, TNF-alpha
177  2001 In vitro redifferentiation of culture-expanded rabbit and human auricular chondrocytes for cartilage reconstruction. IGF-1
178  2001 Isolation and characterization of the murine transforming growth factor-beta2 promoter. ---
179  2001 Response to hypoxia involves transforming growth factor-beta2 and Smad proteins in human endothelial cells. ---
180  2001 Retinoblastoma protein interacts with ATF2 and JNK/p38 in stimulating the transforming growth factor-beta2 promoter. Rb
181  2001 TGF beta 2, LIF and FGF2 cooperate to induce nephrogenesis. LIF
182  2001 The release and activation of transforming growth factor beta2 associated with apoptosis of chick hypertrophic chondrocytes. ---
183  2001 Transcriptional regulation of the transforming growth factor-beta2 gene in glioblastoma cells. CRE/ATF, USF
184  2001 Transforming growth factor beta 2 levels in the aqueous humor in different types of glaucoma and the relation to filtering bleb development. JG, POAG, PSX
185  2001 Transforming growth factor beta2 induced pleurodesis is not inhibited by corticosteroids. ---
186  2001 Transforming growth factor-beta 2 levels in aqueous humor of glaucomatous eyes. EXS, PACG, POAG, SG
187  2001 Transforming growth factor-beta2 induces pleurodesis significantly faster than talc. ---
188  2001 Two novel polymorphisms in the human transforming growth factor beta 2 gene. 5'UTR, PCR, SNP, SSCP
189  2002 Circadian variations of transforming growth factor-beta2 and basic fibroblast growth factor in the rabbit aqueous humor. bFGF
190  2002 Cytokine expression in the uterus of mice with pregnancy loss: effect of maternal immunopotentiation with GM-CSF. GM-CSF, LPS, TNF-alpha
191  2002 Diabetes teratogenicity in mice is accompanied with distorted expression of TGF-beta2 in the uterus. ---
192  2002 Elevated transforming growth factor beta2 enhances apoptosis and contributes to abnormal outflow tract and aortic sac development in retinoic X receptor alpha knockout embryos. ---
193  2002 Expression patterns of cytokines and chemokines genes in human hepatoma cells. HBV, IFN-gamma, IL-10, IP-10, MCP-1, MIP-1alpha, TNF-alpha
194  2002 Induction of regulatory T cells by the immunomodulating cytokines alpha-melanocyte-stimulating hormone and transforming growth factor-beta2. alpha-MSH, EAU, IL, Treg
195  2002 Lens epithelial cell death after cataract surgery. LECs, TUNEL
196  2002 Localization of transforming growth factor beta2 (TGFbeta2) and its receptors, TbetaRI and TbetaRII, in uteri and blastocysts of the stripe-faced dunnart (Sminthopsis macroura) during gastrulation. ---
197  2002 Myostatin and TGF-beta2 gene expression patterns in response to in ovo administration of rhIGF-I during chicken embryonic development. rhIGF-I, RT-PCR
198  2002 Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant. ---
199  2002 Prominent expression of transforming growth factor beta2 gene in the chicken embryonic gonad as revealed by suppressive subtraction cloning. ---
200  2002 Retinal glial cells stimulate microvascular pericyte proliferation via fibroblast growth factor and platelet-derived growth factor in vitro. aFGF, bFGF, CM, PDGF-BB, RGCs, RT-PCR, VEGF
201  2002 The influence of tamoxifen on the secretion of transforming growth factor-beta2 (TGF-beta2) in glioblastomas: in vitro and in vivo findings. TAM
202  2002 Transforming growth factor-12 polymorphism and systemic lupus erythematosus. 5'-UTR, bp, SLE
203  2002 Transforming growth factor-beta 2 heterozygous mutant mice exhibit Cowper's gland hyperplasia and cystic dilations of the gland ducts (Cowper's syringoceles). ---
204  2002 Transforming growth factor-beta 2 is a transcriptional target for Akt/protein kinase B via forkhead transcription factor. FasL
205  2002 Transforming growth factor-beta 3(Tgf-beta3) in a collagen gel delays fusion of the rat posterior interfrontal suture in vivo. IF, Tbetar-II, Tgf-beta3
206  2002 Transforming growth factor-beta2 (TGF-beta2) reverses the inhibitory effects of fibrin sealant on cutaneous wound repair in the pig. ---
207  2002 [Effects of androgen and estrogen on the expressions of basic fibroblast growth factor, transforming growth factor and smoothelin]. bFGF, BPH, DHT
208  2003 Adenoviral gene transfer of GDNF, BDNF and TGF beta 2, but not CNTF, cardiotrophin-1 or IGF1, protects injured adult motoneurons after facial nerve avulsion. BDNF, CNTF, CT-1, GDNF, IGF1
209  2003 Association of INOS, TRAIL, TGF-beta2, TGF-beta3, and IgL genes with response to Salmonella enteritidis in poultry. IgL, iNOS, ISRRP, SE, SNP, TGF-beta3, TRAIL
210  2003 Characterization of proliferating human skeletal muscle-derived cells in vitro: differential modulation of myoblast markers by TGF-beta2. HuSkMC
211  2003 Circulating levels of osteoclast activating cytokines, interleukin-11 and transforming growth factor-beta2, as valuable biomarkers for the assessment of bone turnover in postmenopausal osteoporosis. BALP, BMD, Dpyr, IL-11, OC, PO
212  2003 Conditionally immortalized cell line of inducible metanephric mesenchyme. FGF-2, LIF, MM, RT-PCR, SFRP2
213  2003 Dynamic expression of bFGF and TGFbeta2 in glomus cell grafts of carotid body in rat model of Parkinson disease. bFGF
214  2003 Effects of growth hormone on circulating cytokine network, and left ventricular contractile performance and geometry in patients with idiopathic dilated cardiomyopathy. DCM, ESWS, GH, GM-CSF, IL-10, IL-6, LV, MCP-1, sICAM-1, TNF-alpha, VCFc
215  2003 In vitro chondrogenesis of human bone marrow-derived mesenchymal progenitor cells in monolayer culture: activation by transfection with TGF-beta2. ---
216  2003 Incorporation of vancomycin-supplemented bone incorporation of vancomycin-supplemented bone allografts: radiographical, histopathological and immunohistochemical study in pigs. MIC
217  2003 Influence of argon laser trabeculoplasty on transforming growth factor-beta 2 concentration and bleb scarring following trabeculectomy. ALT, POAG
218  2003 Interactions of corneal cells with transforming growth factor beta 2-modified poly dimethyl siloxane surfaces. AFM, PDMS, PEG, XPS
219  2003 Molecular characterization of a familial translocation implicates disruption of HDAC9 and possible position effect on TGFbeta2 in the pathogenesis of Peters' anomaly. HDAC9, LYPLAL1, PA
220  2003 Response of lens epithelial cells to injury: role of lumican in epithelial-mesenchymal transition. alpha-SMA, EMT, LECs, LUM
221  2003 Smad7 suppresses the inhibitory effect of TGF-beta2 on corneal endothelial cell proliferation and accelerates corneal endothelial wound closure in vitro. ---
222  2003 The effect of TGF-beta2 on human trabecular meshwork extracellular proteolytic system. HTM, MMPs, MT1-MMP, PAI-1, POAG
223  2003 Tissue transglutaminase as a modifying enzyme of the extracellular matrix in PVR membranes. ECM, PVR, RPE, tTGase
224  2003 Transforming growth factor beta2 is released from PC12 cells via the regulated pathway of secretion. CgB
225  2003 [Effect of transforming growth factor beta 2 on phagocytosis in cultured bovine trabecular meshwork cells]. ---
226  2004 17Beta-estradiol confers a protective effect against transforming growth factor-beta2-induced cataracts in female but not male lenses. alpha-SMA
227  2004 Apoptosis of human trabecular meshwork cells induced by transforming growth factor-beta2 in vitro. ---
228  2004 BCL-2-induced glioma cell invasiveness depends on furin-like proteases. FLP, HGF, o-PA
229  2004 Chicken extract affects colostrum protein compositions in lactating women. CE, EGF
230  2004 Effect of folic acid plus glycine supplement on uterine prostaglandin and endometrial granulocyte-macrophage colony-stimulating factor expression during early pregnancy in pigs. COX-1, GM-CSF, ML, PGE2, PGF2 alpha, YL
231  2004 Effect of human papillomavirus type 16 E6 and E7 oncogenes on the activity of the transforming growth factor-beta2 (TGF-beta2) promoter. HPV-16
232  2004 Efficacy of a transforming growth factor beta 2 containing nutritional support formula in a murine model of inflammatory bowel disease. IBD, IEC, SAA
233  2004 Enhanced Dupuytren's disease fibroblast populated collagen lattice contraction is independent of endogenous active TGF-beta2. DD, FPCL
234  2004 Fibroblast growth factor 2: roles of regulation of lens cell proliferation and epithelial-mesenchymal transition in response to injury. BrdU, EMT, FGF-2
235  2004 Function of TGF-beta2 in the growth of chicken primordial germ cells and germinal ridge stroma cells during embryonic development. GRSCs, PGCs
236  2004 Gene expression profiling of mouse condylar cartilage during mastication by means of laser microdissection and cDNA array. HSP-84, HSP-86, IGF-I, IGF2, Ihh, PTHrP
237  2004 Interaction between insulin-like growth factor-1 with other growth factors in serum depleted culture medium for human cartilage engineering. bFGF, IGF-1
238  2004 Lipoxin A4 counteracts synergistic activation of human fibroblast-like synoviocytes. IL-6, LXA4
239  2004 Role of TGF-beta2 in the human hair cycle. DHT
240  2004 Secreted transforming growth factor beta2 activates NF-kappaB, blocks apoptosis, and is essential for the survival of some tumor cells. ---
241  2004 Secretion of cytokines and growth factors as a general cause of constitutive NFkappaB activation in cancer. FGF5, NF-kappaB
242  2004 The aqueous levels of TGF-beta2 in patients with glaucoma. ---
243  2004 The effects of transforming growth factor-beta2 on dopaminergic graft survival. VM
244  2004 The presence of cytokines and growth factors in hydrosalpingeal fluid. EGF, GM-CSF, IFN-gamma, IL-8, LIF, TNF-alpha
245  2004 The role of beta-catenin, TGF beta 3, NGF2, FGF2, IGFR2, and BMP4 in the pathogenesis of mesenteric sclerosis and angiopathy in midgut carcinoids. BMP4, FGF-2, IGFR, MA, MCs, MS, NGF2
246  2004 Thrombospondin-1 in the trabecular meshwork: localization in normal and glaucomatous eyes, and induction by TGF-beta1 and dexamethasone in vitro. POAG, TM, TSP-1
247  2004 [Influence of transforming growth factor-beta2 on production of tumor necrosis factor-alpha and interferon-gamma from placenta of intrahepatic cholestasis of pregnancy]. ELISA, ICP, IFN-gamma, TNF-alpha
248  2005 Control of human hair growth by neurotrophins: brain-derived neurotrophic factor inhibits hair shaft elongation, induces catagen, and stimulates follicular transforming growth factor beta2 expression. BDNF, TrkB
249  2005 Effect of transforming growth factor beta 2 on marrow-infused foam poly(propylene fumarate) tissue-engineered constructs for the repair of critical-size cranial defects in rabbits. beta-TCP, PPF
250  2005 Endometrial expression of immunomodulatory cytokines and their regulators during early pregnancy in bonnet monkeys (Macaca radiata). IL-6, LIF
251  2005 Expression of alphasmooth muscle actin in lens epithelia from human donors and cataract patients. alpha-SMA, ASF, CAT, DON, LECs, PSO
252  2005 Expression of lysyl oxidase and transforming growth factor beta2 in women with severe pelvic organ prolapse. LOX, PCR
253  2005 Expression of TGF-beta2 mRNA and PCNA, FN protein in lens epithelial cells in age-related nuclear and cortex cataract. FN, LECs, PCNA
254  2005 Feto-maternal bone remodeling in normal pregnancy and preeclampsia. IL-6, OC, TNF-alpha
255  2005 Growth factor deposition in anterior subcapsular cataract. alpha-SMA, ASC, ECM, FGF-2, HGF-alpha, LECs, LTBP-1, MAP kinase, TGFbeta1-LAP
256  2005 Peripheral nerve avulsion injuries as experimental models for adult motoneuron degeneration. BDNF, ChAT, GDNF, GIF
257  2005 Strong inflammatory cytokine response in male and strong anti-inflammatory response in female kidney transplant recipients with urinary tract infection. ELISA, IFN-gamma, sIL-1RA, TNF-alpha, UTI
258  2005 TGF-beta2 neutralization inhibits proliferation and activates apoptosis of cerebellar granule cell precurors in the developing cerebellum. ---
259  2005 Transforming growth factor beta 2 promotes the formation of the mouse cochleovestibular ganglion in organ culture. CVG, OV
260  2005 Transforming growth factor beta2 is a neuronal death-inducing ligand for amyloid-beta precursor protein. AD
261  2005 Transforming growth factor-beta 2 causes an acute improvement in the motor performance of transgenic ALS mice. ALS
262  2005 Transforming growth factor-beta inhibits CCAAT/enhancer-binding protein expression and PPARgamma activity in unloaded bone marrow stromal cells. C/EBP, RT-PCR
263  2006 Biochemical and functional modulation of the cartilage collagen network by IGF1, TGFbeta2 and FGF2. FGF-2, IGF1, MMP
264  2006 Breast cyst fluids increase the proliferation of breast cell lines in correlation with their hormone and growth factor concentration. BCF, E1-S, E2-S, EGF, GCD, Pg
265  2006 Determination of active TGF-beta2 in aqueous humor prior to and following cryopreservation. ---
266  2006 Effect of growth factors on proliferation and expression of growth factor receptors in a human lens epithelial cell line. bFGF, EGF, HLECs, IGF-1, RT-PCR
267  2006 Fetal cartilage engineering from amniotic mesenchymal progenitor cells. IGF-1, MPCs
268  2006 Modulation of transforming growth factor beta2 (TGF-beta2) by inositol hexaphosphate in colon carcinogenesis in rats. AOM
269  2006 MUC4-expressing pancreatic adenocarcinomas show elevated levels of both T1 and T2 cytokines: potential pathobiologic implications. IFN-gamma, IL-2, NP, PA, RT-PCR, Th1
270  2006 Oligodendrocyte progenitor cells derived from human embryonic stem cells express neurotrophic factors. BDNF, hES, HGF, OPCs
271  2006 Phase I clinical trial of a TGF-beta antisense-modified tumor cell vaccine in patients with advanced glioma. ---
272  2006 Potential role of tissue transglutaminase in glaucoma filtering surgery. ECM, HTFs, tTGase
273  2006 Profiling the cytokines in gingival crevicular fluid using a cytokine antibody array. Ang, EGF, FGF-4, GCF, GDNF, GRO, IGFBP-3, IL-8, IP-10, OPG, OSM, PARC, PlGF, TIMP-2, TNF-beta, VEGF
274  2006 TGF-beta2 inhibits AKT activation and FGF-2-induced corneal endothelial cell proliferation. BCE, FGF-2, PGE-2
275  2006 Transforming growth factor-beta2 is involved in quantitative genetic variation in thymic involution. HSC
276  2007 A phase III study of subconjunctival human anti-transforming growth factor beta(2) monoclonal antibody (CAT-152) to prevent scarring after first-time trabeculectomy. 5-FU, CACG, IOP, ITT, PEXG, PG, POAG, POAG/CACG
277  2007 Active transforming growth factor-beta2 is increased in the aqueous humor of keratoconus patients. PK
278  2007 Anti-wrinkling effects of the mixture of vitamin C, vitamin E, pycnogenol and evening primrose oil, and molecular mechanisms on hairless mouse skin caused by chronic ultraviolet B irradiation. AP, MAP, MMPs, UV
279  2007 Bone formation zones in heterotopic ossifications: histologic findings and increased expression of bone morphogenetic protein 2 and transforming growth factors beta2 and beta3. BMP-2, HOs
280  2007 Factors affecting the outcome of trabeculectomy: an analysis based on combined data from two phase III studies of an antibody to transforming growth factor beta2, CAT-152. CI, IOP, OR, PG
281  2007 Foxp3 expression in pancreatic carcinoma cells as a novel mechanism of immune evasion in cancer. IL-6, siRNA, Treg
282  2007 Inhibition of TGF-beta2 with AP 12009 in recurrent malignant gliomas: from preclinical to phase I/II studies. PBMCs
283  2007 Integrin beta1-mediated signaling is involved in transforming growth factor-beta2-promoted migration in human lens epithelial cells. FAK, RT-PCR
284  2007 Modulation of morphogenesis by noncanonical Wnt signaling requires ATF/CREB family-mediated transcriptional activation of TGFbeta2. ATF, CREB
285  2007 Postoperative anti-Tgf-beta2 antibody therapy improves intracranial volume and craniofacial growth in craniosynostotic rabbits. ---
286  2007 Presence of an established calcification marker in trabecular meshwork tissue of glaucoma donors. ALP, DEX
287  2007 Regulation of VEGF mRNA expression and protein secretion by TGF-beta2 in human retinal pigment epithelial cells. CAPE, DPI, hRPE, JNK, MAP, NAC, NF-kappaB, PI3K, PKC, PTK, ROS, VEGF
288  2007 Relationships of a transforming growth factor-beta2 single nucleotide polymorphism and messenger ribonucleic acid abundance with bone and production traits in chickens. SNP
289  2007 The role of Hsp70 and Hsp90 in TGF-beta-induced epithelial-to-mesenchymal transition in rat lens epithelial explants. alpha-SMA, EMT, FGF-2
290  2007 The role of versican isoforms V0/V1 in glioma migration mediated by transforming growth factor-beta2. ECM
291  2007 Toll-like receptor triggered dendritic cell maturation and IL-12 secretion are necessary to overcome T-cell inhibition by glioma-associated TGF-beta2. DC, MHC, PGE2, TLR, TNF-alpha
292  2007 What increases outflow resistance in primary open-angle glaucoma? BMP-7
293  2008 Antisense therapeutics for tumor treatment: the TGF-beta2 inhibitor AP 12009 in clinical development against malignant tumors. ---
294  2008 Changes in circulating immunosuppressive cytokine levels of cancer patients after high intensity focused ultrasound treatment. ELISA, HIFU, IL-10, IL-6, TGF-beta1, VEGF
295  2008 Expression of integrin-linked kinase is increased in differentiated cells. ILK
296  2008 Immunohistochemical detection of insulin-like growth factor-I, transforming growth factor-beta2, basic fibroblast growth factor and epidermal growth factor-receptor expression in developing rat ovary. bFGF, EGFR, IGF-I
297  2008 Potent inhibition of cicatricial contraction in proliferative vitreoretinal diseases by statins. MLC, PDR, PVDs, PVR
298  2008 Temporal and spatial expression of TGF-beta2 in tooth crown development in mouse first lower molar. ---
299  2008 trans-3,4'-Dimethyl-3-hydroxyflavanone, a hair growth enhancing active component, decreases active transforming growth factor beta2 (TGF-beta2) through control of urokinase-type plasminogen activator (uPA) on the surface of keratinocytes. t-flavanone, TGF-beta, uPA
300  2008 [Influence of ASODN to the human tenon's fibroblasts in expressing CTGF induced by transforming growth factor beta2]. ASODN, FN, HTF, MT, RT-PCR
301  2008 [Influence of disulfiram on the expression of transforming growth factor-beta2 in form-deprived eyes in chicks]. FDM, RA, RPE
302  2009 Biological effects of native and oxidized low-density lipoproteins in cultured human retinal pigment epithelial cells. AMD, FN, HDL, Laa1, ox, RPE
303  2009 Embryo-induced alterations in the molecular phenotype of primate endometrium. IL-6, PP14, TNF-alpha
304  2009 Expression of the Arf tumor suppressor gene is controlled by Tgfbeta2 during development. MEFs, PHPV
305  2009 Lactate promotes glioma migration by TGF-beta2-dependent regulation of matrix metalloproteinase-2. LDH-A, MMP-2, siLDH-A
306  2009 Neuroprotection of microglial conditioned medium on 6-hydroxydopamine-induced neuronal death: role of transforming growth factor beta-2. CGNs, MCM
307  2009 Potential biomarkers for detecting pulmonary arterial hypertension in patients with systemic sclerosis. ENG, ET-1, IL-8, PAH, PDGF, SSc, TNF-alpha
308  2009 Promotion effect of Schisandra nigra on the growth of hair. EtOH, PCNA
309  2009 Sclera-related gene polymorphisms in high myopia. bFGF, FMOD, HRM, RFLP, SNPs
310  2009 TGF-beta1 and TGF-beta2 strongly enhance the secretion of plasminogen activator inhibitor-1 and matrix metalloproteinase-9 of the human prostate cancer cell line PC-3. MMP, PAI-1
311  2009 Transforming growth factor-beta2 is a molecular determinant for site-specific melanoma metastasis in the brain. ---
312  2009 Transforming growth factor-beta2 upregulates sphingosine kinase-1 activity, which in turn attenuates the fibrotic response to TGF-beta2 by impeding CTGF expression. CTGF, SK-1
313  2010 Activation of cAMP-responsive-element-binding protein by PI3 kinase and p38 MAPK is essential for elevated expression of transforming growth factor beta2 in cancer cells. cAMP, CREB
314  2010 Adenoviral gene transfer of active human transforming growth factor-{beta}2 elevates intraocular pressure and reduces outflow facility in rodent eyes. ECM, IOP, POAG, TM
315  2010 Conversion of vascular endothelial cells into multipotent stem-like cells. ALK2, BMP4, FOP
316  2010 Expansion of human articular chondrocytes and formation of tissue-engineered cartilage: a step towards exploring a potential use of matrix-induced cell therapy. bFGF, FBS, FD2GFs, IGF-I
317  2010 Hydrogen peroxide-induced cellular apoptosis is mediated by TGF-beta2 signaling pathway in cultured human lens epithelial cells. FCM, HLECs, RT-PCR, TbetaRs, TUNEL
318  2010 The relationship between the levels of gonadotropic hormones and OPG, leptin, TGF-beta1 and TGF-beta2 in Chinese adult women. FSH, LH, OPG
319  2010 [Association of serum follicle stimulating hormone with osteoprotegerin, leptin, TGF-beta1, and TGF-beta2 in women]. FSH, OPG, TGF-beta1
320  2010 [Growth factors are markers of placental insufficiency in third-trimester miscarriage]. VEGF
321  2011 Comparative effects of TGF-beta2/Smad2 and TGF-beta2/Smad3 signaling pathways on proliferation, migration, and extracellular matrix production in a human lens cell line. alpha-SMA, PCO, R-Smads
322  2011 Differential mRNA expression in rabbit in vivo pre-implantatory embryos. qrtRT-PCR, VEGF
323  2011 HoxA10 regulates transcription of the gene encoding transforming growth factor beta2 (TGFbeta2) in myeloid cells. AML
324  2011 Increased transforming growth factor-beta2 in epidermal growth factor receptor variant III-positive glioblastoma. EGFRvIII, GBM, IL-10, RT-PCR
325  2011 Inducers of cross-linked actin networks in trabecular meshwork cells. BTM, CLANs, DEX, FCS, TM
326  2011 Influence of race and age on aqueous humor levels of transforming growth factor-beta 2 in glaucomatous and nonglaucomatous eyes. ---
327  2011 Lumican regulates osteosarcoma cell adhesion by modulating TGFbeta2 activity. FN, SLRP
328  2011 NBHA reduces acrolein-induced changes in ARPE-19 cells: possible involvement of TGFbeta. AMD, NBHA, RPE, VEGF
329  2011 Osseointegration by bone morphogenetic protein-2 and transforming growth factor beta2 coated titanium implants in femora of New Zealand white rabbits. BMPs, BV/TV
330  2011 Proteome profiling of heat shock of human primary breast epithelial cells, a dataset report. HSP27
331  2011 Resveratrol targets transforming growth factor-beta2 signaling to block UV-induced tumor progression. RES, SCC
332  2011 RNA interference of transforming growth factor-beta 2 in human respiratory fibroblasts. mRNA
333  2011 Stability of epitheliotrophic factors in autologous serum eye drops from chronic Stevens-Johnson syndrome dry eye compared to non-autoimmune dry eye. ASE, EGF, ELISA, SJS, TGF-beta1
334  2011 The antisense oligonucleotide trabedersen (AP 12009) for the targeted inhibition of TGF-beta2. ---
335  2011 Transforming growth factor Beta2 is required for valve remodeling during heart development. CRTL1, ECM, EMT
336  2011 Transforming growth factor-beta 2 gene silencing with trabedersen (AP 12009) in pancreatic cancer. i.p, LAK
337  2011 Transforming growth factor-beta2 increases extracellular matrix proteins in optic nerve head cells via activation of the Smad signaling pathway. ECM, ERK, JNK, LC, ONH, siRNA
338  2011 Transforming growth factor-beta2 utilizes the canonical Smad-signaling pathway to regulate tissue transglutaminase expression in human trabecular meshwork cells. ECM, GTM, IOP, NTM, si, SIS3, TM
339  2011 [Research progress on proliferative property and capacity of human corneal endothelium]. ---
340  2012 Characterization of a spontaneously immortalized bovine trabecular meshwork cell line. alpha-SMA, BTM, CLANs, Col IV, CTGF, DEX, FN, PAI-1, TM
341  2012 Common TGFbeta2, BMP4, and FOXC1 variants are not associated with primary open-angle glaucoma. BMP4, FOXC1, HTG, IOP, OHT, POAG, SNPs
342  2012 Dexamethasone inhibits TGF-beta2-induced migration of human lens epithelial cells: implications for posterior capsule opacification prevention. DEX, HLECs, MAPK, MMP, PCO
343  2012 Dietary transforming growth factor-beta 2 (TGF-beta2) supplementation reduces methotrexate-induced intestinal mucosal injury in a rat. MTX, TGF-beta
344  2012 DNA sequencing of TGFbeta2 in sporadic patients with tetralogy of Fallot. 5'UTR, CHAD, TOF
345  2012 Metallothionein-dependent up-regulation of TGF-beta2 participates in the remodelling of the myxomatous mitral valve. MMV, VICs
346  2012 Paracrine effect of Wnt11-overexpressing mesenchymal stem cells on ischemic injury. CMs, MSCs, Wnt11
347  2012 Regulatory factor X1-induced down-regulation of transforming growth factor beta2 transcription in human neuroblastoma cells. ERK, RFX
348  2012 TGF-beta affects enterocyte turnover in correlation with TGF-beta receptor expression after massive small bowel resection. SBS
349  2012 The effects of polymorphisms in IL-2, IFN-gamma, TGF-beta2, IgL, TLR-4, MD-2, and iNOS genes on resistance to Salmonella enteritidis in indigenous chickens. IFN-gamma, IgL, IL-2, iNOS, MD-2, TLR4
350  2012 The role of TGF-beta in the pathogenesis of primary open-angle glaucoma. BMP-4, ECM, IOP, POAG
351  2012 The T-box transcription factor Brachyury regulates epithelial-mesenchymal transition in association with cancer stem-like cells in adenoid cystic carcinoma cells. AdCC, AFP, EMT, GFP, shRNA
352  2012 Transforming growth factor-beta inhibits cystogenesis in human autosomal dominant polycystic kidney epithelial cells. ADPKD, CM, MAP, NHK
353  2012 [Association between rs6658835 polymorphism of transforming growth factor beta 2 gene and congenital heart diseases in Chinese Han population]. ASD, CHD, PDA, VSD
354  2012 [Effect of tetrandrine on bax, bcl-2 and TGF-beta2 mRNA expressions in cultured human Tenon's capsule fibroblasts]. Tet
355  2013 Altered TGF-beta2 and bFGF expression in scleral desmocytes from an experimentally-induced myopia guinea pig model. bFGF, LIM, qRT-PCR, SC
356  2013 Antioxidants reduce TGF-beta2-induced gene expressions in human optic nerve head astrocytes. CTGF, ECM, ONH
357  2013 Effects of synbiotic supplementation on breast milk levels of IgA, TGF-beta1, and TGF-beta2. IgA, TGF-beta1
358  2013 Effects of transforming growth factor beta2 and connective tissue growth factor on induction of epithelial mesenchymal transition and extracellular matrix synthesis in human lens epithelial cells. alpha-SMA, CTGF, ECM, FN, HLECs, PCR
359  2013 Everolimus-induced epithelial to mesenchymal transition in immortalized human renal proximal tubular epithelial cells: key role of heparanase. alpha-SMA, EGFR, EMT, EVE, FN, HPSE, MMP9, VIM, WT
360  2013 Exogenous bFGF promotes articular cartilage repair via up-regulation of multiple growth factors. bFGF, BMP-2, GFs, SF, VEGF
361  2013 Histone deacetylase 3 unconventional splicing mediates endothelial-to-mesenchymal transition through transforming growth factor beta2. EndMT, HDAC3
362  2013 Immunological programming by breast milk creates an anti-inflammatory cytokine milieu in breast-fed infants compared to formula-fed infants. ---
363  2013 Inhibition of pirfenidone on TGF-beta2 induced proliferation, migration and epithlial-mesenchymal transition of human lens epithelial cells line SRA01/04. FN, LDH, PCO
364  2013 Mechanism of the DL-alpha-aminoadipic acid inhibitory effect on form-deprived myopia in guinea pig. DL-alpha-AAA, VIP
365  2013 Mechanisms for PDGF, a serum cytokine, stimulating loss of corneal keratocyte crystallins. mRNA, PDGF, TKT
366  2013 Requirement for integrin-linked kinase in neural crest migration and differentiation and outflow tract morphogenesis. BMP, FACS, ILK, NCAM
367  2013 Sulfadiazine modified PDMS as a model material with the potential for the mitigation of posterior capsule opacification (PCO). alpha-SMA, MMPs, PCO, PDMS, PEG
368  2013 Suppression of type I collagen in human scleral fibroblasts treated with extremely low-frequency electromagnetic fields. ELF-EMFs, FGF-2, HFSFs, MAPK, MMP-2, RPE, RT-PCR
369  2013 Syndecan-2 is a key regulator of transforming growth factor beta 2/Smad2-mediated adhesion in fibrosarcoma cells. HS, SDC2
370  2013 TGF-beta2 dictates disseminated tumour cell fate in target organs through TGF-beta-RIII and p38alpha/beta signalling. BM, CDK4, DTCs, HNSCC, TGF-beta-RI
371  2013 The epigenetic modifier trichostatin A, a histone deacetylase inhibitor, suppresses proliferation and epithelial-mesenchymal transition of lens epithelial cells. ASC, EMT, HDACs, LECs, PCO, TSA
372  2013 The G-quadruplex augments translation in the 5' untranslated region of transforming growth factor beta2. UTR
373  2013 The genotype and expression of the TGFbeta2 gene in children with congenital conotruncal defects. CTDs
374  2013 Thrombospondin-1-induced smooth muscle cell chemotaxis and proliferation are dependent on transforming growth factor-beta2 and hyaluronic acid synthase. HAS, TSP-1, VSMC
375  2013 Topical application of recombinant type VII collagen incorporates into the dermal-epidermal junction and promotes wound closure. AFs, alpha-SMA, DEJ, rC7, RDEB
376  2013 Urban particulate matter induces pro-remodeling factors by airway epithelial cells from healthy and asthmatic children. AECs, ALI, MUC5AC, PBS, UPM, VEGF
377  2013 Vitamin E reduces TGF-beta2-induced changes in human trabecular meshwork cells. ECM, MMP-2, PCR, TM
378  2013 [Effects of transforming growth factor-beta2 on transdifferentiation, extracellular matrix synthesis and connective tissue growth factor expression of human lens epithelium cells]. CTGF, FN, HLEC
379  2014 A Wnt-TGFbeta2 axis induces a fibrogenic program in muscle stem cells from dystrophic mice. ---
380  2014 Adaptation of ovarian cancer cells to the peritoneal environment: Multiple mechanisms of the developmental patterning gene HOXA9. ---
381  2014 Blockade of Jagged/Notch pathway abrogates transforming growth factor beta2-induced epithelial-mesenchymal transition in human retinal pigment epithelium cells. EMT, PDR, PVR, RPE
382  2014 Effect of human Wharton's jelly mesenchymal stem cell paracrine signaling on keloid fibroblasts. IL, WJ-MSC-CM, WJ-MSCs
383  2014 Effects of transforming growth factor-beta2 on myocilin expression and secretion in human primary cultured trabecular meshwork cells. AH, ELISA, IOP, MYOC, POAG, TM
384  2014 Endothelial lineage differentiation from induced pluripotent stem cells is regulated by microRNA-21 and transforming growth factor beta2 (TGF-beta2) pathways. ECs, iPSC, miR-21
385  2014 Endothelial-mesenchymal transition in normal human esophageal endothelial cells cocultured with esophageal adenocarcinoma cells: role of IL-1beta and TGF-beta2. alpha-SMA, EAC, EndoMT, FSP1, HEMEC, vWF
386  2014 Generation of mice carrying a knockout-first and conditional-ready allele of transforming growth factor beta2 gene. ---
387  2014 HOXA10 promotes cell invasion and MMP-3 expression via TGFbeta2-mediated activation of the p38 MAPK pathway in pancreatic cancer cells. MMP-3
388  2014 Human aqueous humor levels of TGF- beta2: relationship with axial length. ---
389  2014 Impact of the controlled release of a connexin 43 peptide on corneal wound closure in an STZ model of type I diabetes. A-PLO, alphaCT1, Cx43, ESR1, GLUT4, I-TAC, Krt8, MC, STZ, TNF-alpha
390  2014 Inhibition by female sex hormones of collagen gel contraction mediated by retinal pigment epithelial cells. alpha-SMA, MLC, MMP, PVR, RPE
391  2014 Integrin alphavbeta3 drives slug activation and stemness in the pregnant and neoplastic mammary gland. ---
392  2014 Kaposi's sarcoma-associated herpesvirus downregulates transforming growth factor beta2 to promote enhanced stability of capillary-like tube formation. KS, KSHV
393  2014 Primary culture of avian embryonic heart forming region cells to study the regulation of vertebrate early heart morphogenesis by vitamin A. HFR, NEO, RA, VEGF-A
394  2014 Safety evaluation of a whey protein fraction containing a concentrated amount of naturally occurring TGF-beta2. NOAEL, PND
395  2014 TGF-beta2-mediated ocular hypertension is attenuated in SPARC-null mice. CTGF, ECM, PAI-1, SPARC, TM
396  2014 The attenuation of Moutan Cortex on oxidative stress for renal injury in AGEs-induced mesangial cell dysfunction and streptozotocin-induced diabetic nephropathy rats. CAT, DN, GSH-Px, MC, MDA, OS
397  2014 The complex interplay between ERK1/2, TGFbeta/Smad, and Jagged/Notch signaling pathways in the regulation of epithelial-mesenchymal transition in retinal pigment epithelium cells. EMT, PVR, RPE
398  2014 The gene expression patterns of BMPR2, EP300, TGFbeta2, and TNFAIP3 in B-Lymphoma cells. EP300, GAPDH, qRT-PCR, TNFAIP3
399  2014 The role of TGF-beta2 and bone morphogenetic proteins in the trabecular meshwork and glaucoma. AH, BMPs, ECM, IOP, POAG, TM
400  2014 Thrombospondin-1-induced vascular smooth muscle cell migration and proliferation are functionally dependent on microRNA-21. ERK, HAS2, miR-21, TSP-1, VSMC
401  2014 Tolerogenic dendritic cells suppress murine corneal allograft rejection by modulating CD28/CTLA-4 expression on regulatory T cells. ACAID, BMDCs, DCs, tolDCs
402  2014 Transforming growth factor-beta2 and endotoxin interact to regulate homeostasis via interleukin-8 levels in the immature intestine. IF, LPS, NEC
403  2014 Transforming growth factor-beta2 induces morphological alteration of human corneal endothelial cells in vitro. ECM, HCECs
404  2014 Trichostatin A, a histone deacetylase inhibitor, suppresses proliferation and epithelial-mesenchymal transition in retinal pigment epithelium cells. EMT, HDACs, PVR, RPE, TSA
405  2015 Aldose Reductase Mediates Transforming Growth Factor beta2 (TGF-beta2)-Induced Migration and Epithelial-To-Mesenchymal Transition of Lens-Derived Epithelial Cells. AR, Co-IP, EMT, MMP, PCO, PLA, qPCR
406  2015 An Inducible TGF-beta2-TGFbetaR Pathway Modulates the Sensitivity of HNSCC Cells to Tyrosine Kinase Inhibitors Targeting Dominant Receptor Tyrosine Kinases. EGFR, FGFRs, HNSCC, TGF-betaRs, TKIs
407  2015 Attenuation of EMT in RPE cells and subretinal fibrosis by an RAR-gamma agonist. AMD, EMT, MMP, RARgamma, RPE
408  2015 Combined silencing of TGF-beta2 and Snail genes inhibit epithelial-mesenchymal transition of retinal pigment epithelial cells under hypoxia. alpha-SMA, AMD, EMT, RPE
409  2015 Comparative analysis of mesenchymal stem cell and embryonic tendon progenitor cell response to embryonic tendon biochemical and mechanical factors. FGF4, MSCs, TPCs
410  2015 Cytokine profile in drug-naive, first episode patients with psychosis. ELISA, IL
411  2015 Does the Cerebrospinal Fluid Reflect Altered Redox State But Not Neurotrophic Support Loss in Parkinson's Disease? CNS, CSF, GPx, GR, GST, PD, PRDXs, SODs, TGF-beta1
412  2015 Donepezil Regulates 1-Methyl-4-phenylpyridinium-Induced Microglial Polarization in Parkinson's Disease. AD, DAergic, IL, STAT6, TNF
413  2015 Hairless Up-Regulates Tgf-beta2 Expression via Down-Regulation of miR-31 in the Skin of "Hairpoor" (HrHp) Mice. HF, Hp, hr
414  2015 Hic-5 Regulates Actin Cytoskeletal Reorganization and Expression of Fibrogenic Markers and Myocilin in Trabecular Meshwork Cells. AH, alpha-SMA, FA, HTM, siRNA, TM
415  2015 Identification of the proliferative effect of Smad2 and 3 in the TGF beta2/Smad signaling pathway using RNA interference in a glioma cell line. CNS, GBM, sh, Smad
416  2015 Implication of Smad2 and Smad3 in transforming growth factor-beta-induced posterior capsular opacification of human lens epithelial cells. EMT, PCO
417  2015 Inflammatory Cytokine-Mediated Regulation of Thrombospondin-1 and CD36 in Conjunctival Cells. EDE, TSP-1, WT
418  2015 Intrinsic TGF-beta2-triggered SDF-1-CXCR4 signaling axis is crucial for drug resistance and a slow-cycling state in bone marrow-disseminated tumor cells. BM, DTCs, HNSCC, SDF-1
419  2015 MicroRNA-153 inhibits osteosarcoma cells proliferation and invasion by targeting TGF-beta2. EGFR, IGFBP-3, miRNAs
420  2015 Neovibsanin B increases extracellular matrix proteins in optic nerve head cells via activation of Smad signalling pathway. ECM, JNK, LC, ONH, siRNA
421  2015 Resveratrol inhibits epithelial-mesenchymal transition of retinal pigment epithelium and development of proliferative vitreoretinopathy. EMT, MET, PVR, RESV, RPE
422  2015 TGF-beta2 stimulates Tenon's capsule fibroblast proliferation in patients with glaucoma via suppression of miR-29b expression regulated by Nrf2. ChIP
423  2015 TGFbeta2 differentially modulates smooth muscle cell proliferation and migration in electrospun gelatin-fibrinogen constructs. ECM, SMCs
424  2015 Transforming growth factor beta2 (TGF-beta2)-induced connective tissue growth factor (CTGF) expression requires sphingosine 1-phosphate receptor 5 (S1P5) in human mesangial cells. CTGF, S1P5
425  2015 [The influence of lentivirus-miRNA-184 on epithelial-mesenchcymal transition of human lens epithelial cells in vitro]. alpha-SMA, EMT, HLEC, VIM
426  2016 A phase III study evaluating oral glutamine and transforming growth factor-beta 2 on chemotherapy-induced toxicity in patients with digestive neoplasm. CP, GI
427  2016 All-Trans Retinoic Acid Attenuates Hypoxia-Induced Injury in NRK52E Cells via Inhibiting NF-x03BA;B/VEGF and TGF-beta2/VEGF Pathway. ATRA, Scpep1, VEGF
428  2016 Bioactive factors in milk across lactation: Maternal effects and influence on infant growth in rhesus macaques (Macaca mulatta). APN, EGF
429  2016 CtBP2 Regulates TGFbeta2-Induced Epithelial-Mesenchymal Transition Through Notch Signaling Pathway in Lens Epithelial Cells. alpha-SMA, CtBP2, Cx43, DAPT, EMT, LECs, NICD, PCO
430  2016 Effect of NF-kappaB p65 antisense oligodeoxynucleotide on transdifferentiation of normal human lens epithelial cells induced by transforming growth factor-beta2. alpha-SMA, ASODN, DMEM, MS-ODN, NF-kappaB p65, RT-PCR
431  2016 EGR-1 is an active transcription factor in TGF-beta2-mediated small intestinal cell differentiation. Egr-1
432  2016 Elevated TGF-beta2 level in aqueous humor of cataract patients with high myopia: Potential risk factor for capsule contraction syndrome. alpha-SMA, LECs, NC
433  2016 Elevated Transforming Growth Factor-beta2 in the Aqueous Humor: A Possible Explanation for High Rate of Capsular Contraction Syndrome in High Myopia. ---
434  2016 Folliculostellate cell interacts with pericyte via TGFbeta2 in rat anterior pituitary. ECM
435  2016 Human trabecular meshwork cells express BMP antagonist mRNAs and proteins. BMP, ECM, TM, WB
436  2016 Levels of innate immune factors in preterm and term mothers' breast milk during the 1st month postpartum. HD5, LZ, sCD14
437  2016 Matrix metalloproteinase-2 (MMP-2), MMP-9, tissue inhibitor of matrix metalloproteinases (TIMP-1) and transforming growth factor-beta2 (TGF-beta2) expression in eutopic endometrium of women with peritoneal endometriosis. MMP-2, MMPs
438  2016 Metformin inhibits proliferation and migration of glioblastoma cells independently of TGF-beta2. BTICs, GBM
439  2016 MicroRNA-141 inhibits glioma cells growth and metastasis by targeting TGF-beta2. miR-141
440  2016 Molecular profiling of a simple rat model of open tibial fractures with hematoma and periosteum disruption. BMP-6, bmp-7, IL-1beta
441  2016 Reduced Contractility and Motility of Prostatic Cancer-Associated Fibroblasts after Inhibition of Heat Shock Protein 90. 17-DMAG, CAF, Hsp90
442  2016 Stiffness-controlled three-dimensional collagen scaffolds for differentiation of human Wharton's jelly mesenchymal stem cells into cardiac progenitor cells. EDC, MSCs, NHS
443  2016 Tetramethylpyrazine Attenuates Transdifferentiation of TGF-beta2-Treated Human Tenon's Fibroblasts. alpha-SMA, ECM, HTFs, MAPK, PCNA, TMP
444  2016 TGF-beta2 induces epithelial-mesenchymal transition in cultured human lens epithelial cells through activation of the PI3K/Akt/mTOR signaling pathway. EMT, HLE, mTOR, PI3K
445  2016 The extracellular matrix regulates the effect of decorin and transforming growth factor beta-2 (TGF-beta2) on myoblast migration. ECM, TGF-beta
446  2016 The membrane trafficking and functionality of the K+-Cl- co-transporter KCC2 is regulated by TGF-beta2. CREB, Rab11b, STED
447  2016 The relationship between anti-vascular endothelial growth factor and fibrosis in proliferative retinopathy: clinical and laboratory evidence. CNTF, CTGF, IVB, PDR
448  2016 Transforming growth factor-beta2 increases the capacity of retinal pigment epithelial cells to induce the generation of regulatory T cells. IDO, Nrf2, RPE
449  2016 [The expression of transcription factors Snail and Slug in epithelial-mesenchymal transition of human lens epithelial cells induced by transforming growth factor-beta2]. EMT, HLEC
450  2017 Autophagy regulates Endothelial-Mesenchymal transition by decreasing the phosphorylation level of Smad3. Co-IP, EndoMT, HRMECs
451  2017 Changes in the cytokine profile in first-episode, drug-naive patients with psychosis after short-term antipsychotic treatment. ELISA, IL, PANSS
452  2017 Comparison of lens oxidative damage induced by vitrectomy and/or hyperoxia in rabbits. ---
453  2017 Crocetin inhibits the proliferation, migration and TGF-beta2-induced epithelial-mesenchymal transition of retinal pigment epithelial cells. EMT, PCNA, RPE
454  2017 Cyclosporine A inhibits TGF-beta2-induced myofibroblasts of primary cultured human pterygium fibroblasts. CsA
455  2017 Downregulation of CITED2 contributes to TGFbeta-mediated senescence of tendon-derived stem cells. TDSCs
456  2017 Effect of benzalkonium chloride on trabecular meshwork cells in a new in vitro 3D trabecular meshwork model for glaucoma. BAK, CLAN, DEX, IL-6, IL-8, p-hTMCs
457  2017 Evaluation of zinc finger E-box binding homeobox 1 and transforming growth factor-beta2 expression in bladder cancer tissue in comparison with healthy adjacent tissue. BC, PCR, ZEB1
458  2017 Expressions of TGF-beta2, bFGF and ICAM-1 in lens epithelial cells of complicated cataract with silicone oil tamponade. bFGF, ICAM-1, LECs, mRNA
459  2017 Featured Article: Invitro development of personalized cartilage microtissues uncovers an individualized differentiation capacity of human chondrocytes. ---
460  2017 First-in-human phase I study of ISTH0036, an antisense oligonucleotide selectively targeting transforming growth factor beta 2 (TGF-beta2), in subjects with open-angle glaucoma undergoing glaucoma filtration surgery. AEs, ERG, IOP, MMC, POAG, TE
461  2017 Heterochronic Pellet Assay to Test Cell-cell Communication in the Mouse Retina. RGC, RPCs, Shh
462  2017 Human aqueous humor levels of transforming growth factor-beta2: Association with matrix metalloproteinases/tissue inhibitors of matrix metalloproteinases. MMPs, TIMPs
463  2017 Identification of gene markers associated with metastasis in clear cell renal cell carcinoma. ccRCC, CMap, DEGs, LAMA, NR4A1, PPI, RHOB, TNF
464  2017 Intestinal immune responses of Jian carp against Aeromonas hydrophila depressed by choline deficiency: Varied change patterns of mRNA levels of cytokines, tight junction proteins and related signaling molecules among three intestinal segments. IFN-gamma2b, IkappaB, IL, JAK3, LEAP, MyD88, NF-kappaB, STAT5, TLR4, TNF-alpha
465  2017 Long noncoding RNA expression profile in HLE B-3 cells during TGF-beta2-induced epithelial-mesenchymal transition. EMT, GO, HLE B-3, KEGG, LECs, lncRNAs, PCO, qRT-PCR
466  2017 MicroRNA-30b controls endothelial cell capillary morphogenesis through regulation of transforming growth factor beta 2. HUVECs, miRNA, VEGF
467  2017 Molecular analysis of endometrial inflammation in preterm birth. CTGF, IL10RA, PTB, SPTB, TEK
468  2017 Patterns of milk macronutrients and bioactive molecules across lactation in a western lowland gorilla (Gorilla gorilla) and a Sumatran orangutan (Pongo abelii). EGF
469  2017 Periostin in vitreoretinal diseases. FVM, PVR
470  2017 Role of Vascular Endothelial Growth Factor and Transforming Growth Factor-beta2 in Rat Bone Tissue after Bone Fracture and Placement of Titanium Implants with Bioactive Bioresorbable Coatings. VEGF
471  2017 SRGN-TGFbeta2 regulatory loop confers invasion and metastasis in triple-negative breast cancer. SRGN, TNBC
472  2017 Statins reduce TGF-beta2-modulation of the extracellular matrix in cultured astrocytes of the human optic nerve head. ECM, LC, ONH
473  2017 TGF-beta induces phosphorylation of phosphatase and tensin homolog: implications for fibrosis of the trabecular meshwork tissue in glaucoma. ECM, IOP, POAG, PTEN, TM
474  2017 TGFbeta2 Induces the Formation of Cross-Linked Actin Networks (CLANs) in Human Trabecular Meshwork Cells Through the Smad and Non-Smad Dependent Pathways. AH, CLANs, DAPI, ERK, JNK, NTM, POAG, ROCK, TM
475  2017 Trabecular meshwork stiffness in glaucoma. AFM, DEX, IOP, NO, POAG, TM
476  2017 Transforming Growth Factor-beta2 Downregulates Major Histocompatibility Complex (MHC) I and MHC II Surface Expression on Equine Bone Marrow-Derived Mesenchymal Stem Cells Without Altering Other Phenotypic Cell Surface Markers. MHC, MSCs
477  2018 Altered Decorin Biology in Proliferative Vitreoretinopathy: A Mechanistic and Cohort Study. EMT, PVR, RRD
478  2018 Comparison of efficacy, complications and TGF-beta2 expression between DHS and PFNA in elderly patients with osteoporotic femoral intertrochanteric fracture. DHS, PFNA
479  2018 Discovery and Preclinical Development of Netarsudil, a Novel Ocular Hypotensive Agent for the Treatment of Glaucoma. HTM, IOP, NET, ROCK, TM
480  2018 Effect of Endothelial Microparticles Induced by Hypoxia on Migration and Angiogenesis of Human Umbilical Vein Endothelial Cells by Delivering MicroRNA-19b. EMPs, HUVECs, miR, MPs
481  2018 Effect of HTST and Holder Pasteurization on the Concentration of Immunoglobulins, Growth Factors, and Hormones in Donor Human Milk. DHM, EGF, HoP, HTST, Igs
482  2018 Effect of transforming growth factor-beta2 on biological regulation of multilayer primary chondrocyte culture. ---
483  2018 Effects of Interleukin-6 on posterior capsular opacification. alpha-SMA, ECM, EMT, FN, HLECs, IL-6, PCO
484  2018 Elevated TGF beta2 serum levels in Emery-Dreifuss Muscular Dystrophy: Implications for myocyte and tenocyte differentiation and fibrogenic processes. ---
485  2018 Fibroblast-derived exosomes promote epithelial cell proliferation through TGF-beta2 signalling pathway in severe asthma. ---
486  2018 Heparin functionalization increases retention of TGF-beta2 and GDF5 on biphasic silk fibroin scaffolds for tendon/ligament-to-bone tissue engineering. AdMCs, GDF5
487  2018 Immunological monitoring for prediction of clinical response to antitumor vaccine therapy. VEGF-A
488  2018 Impact of targeting transforming growth factor beta-2 with antisense OT-101 on the cytokine and chemokine profile in patients with advanced pancreatic cancer. OS, PaC
489  2018 In vitro inhibition of proliferation, migration and epithelial-mesenchymal transition of human lens epithelial cells by fasudil. EMT, MLC, PCO, Rock
490  2018 Interleukin-6-mediated trans-signaling inhibits transforming growth factor-beta signaling in trabecular meshwork cells. HTM, MLC2, POAG, sIL-6R
491  2018 LncRNA HOTAIR mediates TGF-beta2-induced cell growth and epithelial-mesenchymal transition in human lens epithelial cells. EMT, LECs, lncRNA, PCO, siRNA
492  2018 miR-466a Targeting of TGF-beta2 Contributes to FoxP3+ Regulatory T Cell Differentiation in a Murine Model of Allogeneic Transplantation. DLN, miRNA, Treg
493  2018 Optimizing a 3D model system for molecular manipulation of tenogenesis. ---
494  2018 Runx2-I is an Early Regulator of Epithelial-Mesenchymal Cell Transition in the Chick Embryo. EMT
495  2018 Serenoa repens extracts promote hair regeneration and repair of hair loss mouse models by activating TGF-beta and mitochondrial signaling pathway. Bax, Bcl-2, DHT, HACAT, HE, LSESr, MTT
496  2018 TGF-beta Signaling Accelerates Senescence of Human Bone-Derived CD271 and SSEA-4 Double-Positive Mesenchymal Stromal Cells. DPMSCs, MSCs
497  2018 TGF-beta2, EGF, and FGF21 Growth Factors Present in Breast Milk Promote Mesenteric Lymph Node Lymphocytes Maturation in Suckling Rats. EGF, FGF21, IL, MLNs, NK
498  2018 TGFbeta-facilitated optic fissure fusion and the role of bone morphogenetic protein antagonism. BMP, ECM, fsta, grem2b
499  2018 Transforming growth factor beta2 (TGFbeta2) signaling plays a key role in glucocorticoid-induced ocular hypertension. ATF4, CHOP, DEX, ECM, ER, GC, IOP, TGF-beta, TM
500  2019 Causative glaucoma treatment: promising targets and delivery systems. CTGF, IOP, NO, ROCK
501  2019 Effect of N-carbamoylglutamate supplementation on the growth performance, antioxidant status and immune response of mirror carp (Cyprinus carpio) fed an arginine-deficient diet. Arg, CAT, DI, FCR, FWB, GPx, IL-10, IL-1beta, IL-8, MDA, MI, NCG, NO, PER, PI, SOD, TNF-alpha, TNOS, WGR
502  2019 Higher TGF-beta2 Level in the Aqueous Humor of the Second Eye Versus the First Eye in the Course of Sequential Cataract Surgery. AH
503  2019 Inhibitory role of transforming growth factor beta2 in experimental autoimmune anterior uveitis. EAAU, IAU, LNs, MAA
504  2019 MicroRNA-153 affects nasopharyngeal cancer cell viability by targeting TGF-beta2. Bcl-2, miR-153, NPC
505  2019 Silencing fibroblast growth factor 7 inhibits krypton laser-induced choroidal neovascularization in a rat model. CNV, FGF, siRNA, VEGF
506  2019 TGF-beta2 is an exercise-induced adipokine that regulates glucose and fatty acid metabolism. ---
507  2019 The prognosis of trabeculectomy in primary angle-closure glaucoma patients. PACG, TSP-1